Phathom Pharmaceuticals, Inc.
PHAT· Nasdaq
PHATPhathom Pharmaceuticals, Inc.
Filed Aug 10, 2021 · 10-Q · 41 days after period end · 0001564590-21-042895
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Net Income | -$36.55M | -$21.10M | -$87.76M | -$260.00K |
| EPS Diluted | -$1.00 | -$0.64 | -$13.11 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Phathom Pharmaceuticals, Inc. · CIK 1783183 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Aug 10, 2021 · 41 d after period end
